FALLICA, ANTONINO NICOLO'
 Distribuzione geografica
Continente #
NA - Nord America 437
EU - Europa 276
AS - Asia 106
AF - Africa 50
SA - Sud America 24
OC - Oceania 2
Totale 895
Nazione #
US - Stati Uniti d'America 433
IT - Italia 164
SG - Singapore 82
IE - Irlanda 43
CI - Costa d'Avorio 41
DE - Germania 25
BR - Brasile 23
CN - Cina 23
ES - Italia 17
RU - Federazione Russa 8
SN - Senegal 8
GB - Regno Unito 4
UA - Ucraina 4
CA - Canada 3
CH - Svizzera 3
AU - Australia 2
FR - Francia 2
SE - Svezia 2
CL - Cile 1
CZ - Repubblica Ceca 1
FI - Finlandia 1
KE - Kenya 1
LU - Lussemburgo 1
MX - Messico 1
NL - Olanda 1
PK - Pakistan 1
Totale 895
Città #
Chandler 112
Santa Clara 97
Singapore 59
Dublin 43
Abidjan 41
Catania 41
Chicago 34
Ashburn 24
Boardman 22
Barcelona 14
Bremen 11
Cambridge 11
Civitanova Marche 11
Lawrence 11
Andover 10
Dakar 8
Los Angeles 6
Redmond 6
São Paulo 6
Wilmington 5
Moscow 4
Salerno 4
Arezzo 3
Des Moines 3
Gela 3
Hefei 3
Nanjing 3
Padova 3
Palermo 3
Pozzallo 3
Rome 3
Santa Maria di Licodia 3
Cagliari 2
Ferrara di Monte Baldo 2
Foggia 2
Ludwigshafen 2
Madrid 2
Nanchang 2
Naples 2
Seattle 2
Toronto 2
Ananindeua 1
Atripalda 1
Augusta 1
Bariri 1
Brno 1
Brooklyn 1
Canberra 1
Canoas 1
Caruaru 1
Corigliano Calabro 1
Curitiba 1
Dallas 1
Dongyang 1
Edinburgh 1
Esslingen am Neckar 1
Fairfield 1
Ferrara 1
Garbagnate Milanese 1
Goiânia 1
Guarujá 1
Hebei 1
Hwang Chow 1
Itaboraí 1
Jinzhong 1
Juneau 1
Lahore 1
Lappeenranta 1
Latina 1
Leawood 1
London 1
Luxembourg 1
Marseille 1
Melbourne 1
Messina 1
Milan 1
Misterbianco 1
Munich 1
Nairobi 1
New York 1
Novara 1
Nuremberg 1
Ottawa 1
Petrópolis 1
Phoenix 1
Piazza Armerina 1
Piedimonte Etneo 1
Piemonte 1
Ponte Nova 1
Porto San Giorgio 1
Redwood City 1
Reggio Calabria 1
Ribeirão Preto 1
Rimini 1
Rio Grande 1
Salvador 1
Santiago 1
Shenyang 1
São Carlos 1
Taboão da Serra 1
Totale 687
Nome #
Discovery of Novel Acetamide-Based Heme Oxygenase-1 Inhibitors with Potent in Vitro Antiproliferative Activity 116
Synthesis of “no-light activated” Ciprofloxacin and Norfloxacin derivatives as potential biofilm dispersant agents 86
Recent Advances in the Development of Sigma Receptor Ligands as Cytotoxic Agents: A Medicinal Chemistry Perspective 73
Heme Oxygenase-2 (HO-2) as a therapeutic target: Activators and inhibitors 71
New selective Sigma-1/HDACi prodrugs for neurodegenerative disorders 70
Identification of a potent heme oxygenase-2 (HO-2) inhibitor by targeting the secondary hydrophobic pocket of the HO-2 western region 67
Novel mutual prodrug of 5-fluorouracil and heme oxygenase-1 inhibitor (5-FU/HO-1 hybrid): design and preliminary in vitro evaluation 65
Targeting the hydrophobic heme oxygenase-1 western region for the identification of novel and selective azole-based inhibitors. 62
Growing the molecular architecture of imidazole-like ligands in HO-1 complexes 58
From far west to east: Joining the molecular architecture of imidazole-like ligands in ho-1 complexes 52
Structure-activity relationships of mixed σ1R/σ2R ligands with antiproliferative and anticancer effects 50
The potential role of sildenafil in cancer management through epr augmentation 41
Curcumin I-SMA nanomicelles as promising therapeutic tool to tackle bacterial infections 33
Targeting del sistema enzimatico dell'eme ossigenasi come nuovo approccio nella terapia antitumorale 31
Synthesis and in Vitro Evaluation of CAPE Derivatives as Ferroptosis Inducers in Triple Negative Breast Cancer 30
The Promise of Nanotechnology in Personalized Medicine 28
Totale 933
Categoria #
all - tutte 3.616
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.616


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202 0 0 0 0 0 0 0 0 0 0 1 1
2020/202132 0 0 3 9 8 0 2 2 0 1 4 3
2021/2022130 11 8 24 3 16 2 23 10 7 5 0 21
2022/2023264 26 18 7 45 23 45 1 36 45 2 12 4
2023/2024126 4 13 4 3 12 55 1 2 3 6 13 10
2024/2025350 5 53 18 36 90 56 15 4 22 38 13 0
Totale 933